{ "docId": "019de071-94a0-75ef-b86b-e4894fa7dc1d", "docSlug": "8b4d61768a47893d5f24ee0f1f9ae717", "documentTitle": "argenx SE | Results Presentation Deck | 20 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "pageCount": 20, "prevPage": 4, "nextPage": 6, "slideType": "kpi_overview", "function": "analyze_data", "density": "overcrowded", "nDataPoints": 4, "notes": "The slide uses a circular layout to present four distinct clinical KPIs with supporting descriptive text below each.", "elementsJson": null, "metadataConfidence": 1, "imagePath": null, "slideHref": "/slides/019de071-94a0-75ef-b86b-e4894fa7dc1d/5", "deckHref": "/decks/019de071-94a0-75ef-b86b-e4894fa7dc1d", "deckJsonHref": "/decks/019de071-94a0-75ef-b86b-e4894fa7dc1d.json", "deckAnchorHref": "/decks/019de071-94a0-75ef-b86b-e4894fa7dc1d#slide-5", "components": [ { "bbox": { "h": 0.05, "w": 0.45, "x": 0.05, "y": 0.92 }, "kind": "disclaimer", "text": "Primary endpoint: MG-ADL responder ≥2-point improvement for at least four consecutive weeks during the first cycle* First secondary endpoint: QMG responder ≥3-point improvement for at least four consecutive weeks during the first cycle*", "attrs": null, "subkind": null, "toolName": null, "toolSlug": null, "confidence": null, "componentId": "16c6aae5-a2b0-4065-a616-1492e509d634", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.05, "w": 0.4, "x": 0.52, "y": 0.92 }, "kind": "disclaimer", "text": "Efgartigimod is an investigational agent that is not currently approved for use by any regulatory agency as efficacy and safety have not been established.", "attrs": null, "subkind": null, "toolName": null, "toolSlug": null, "confidence": null, "componentId": "996b2214-b9de-4c16-97d3-21931779b81c", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.3, "w": 0.2, "x": 0.75, "y": 0.2 }, "kind": "metric", "text": "89% Duration of response", "attrs": null, "subkind": "big-number", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "270c7e22-8fb6-42cb-a03b-da995d0ebba1", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.3, "w": 0.2, "x": 0.28, "y": 0.2 }, "kind": "metric", "text": "84% Onset of Action", "attrs": null, "subkind": "big-number", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "b4fcc709-fd70-448c-9a2e-c605fa5abe0c", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.3, "w": 0.2, "x": 0.52, "y": 0.2 }, "kind": "metric", "text": "59% MSE Responses", "attrs": null, "subkind": "big-number", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "da854d1a-0f97-4de0-993d-a215187df367", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.3, "w": 0.2, "x": 0.05, "y": 0.2 }, "kind": "metric", "text": "79% Response Rate", "attrs": null, "subkind": "big-number", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "f1870342-fe51-4849-897f-547978ae1657", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.05, "w": 0.2, "x": 0.52, "y": 0.78 }, "kind": "subtitle", "text": "MG-ADL responders achieved minimal symptom expression (MG-ADL of 0 or 1)", "attrs": null, "subkind": null, "toolName": null, "toolSlug": null, "confidence": null, "componentId": "62051587-6773-4ede-958c-22d01c7de178", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.05, "w": 0.2, "x": 0.28, "y": 0.78 }, "kind": "subtitle", "text": "MG-ADL responders within first two weeks of treatment", "attrs": null, "subkind": null, "toolName": null, "toolSlug": null, "confidence": null, "componentId": "b8645c67-bf47-4523-84ca-3beec70b04c0", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.05, "w": 0.2, "x": 0.75, "y": 0.78 }, "kind": "subtitle", "text": "MG-ADL responders experienced duration of response longer than 6 weeks", "attrs": null, "subkind": null, "toolName": null, "toolSlug": null, "confidence": null, "componentId": "ec403753-6daf-469a-8cbd-74292c9495b5", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.05, "w": 0.2, "x": 0.05, "y": 0.78 }, "kind": "subtitle", "text": "MG-ADL responders during first two cycles", "attrs": null, "subkind": null, "toolName": null, "toolSlug": null, "confidence": null, "componentId": "eedfeb7f-2138-4cc0-aeec-de563b18e27e", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.08, "w": 0.5, "x": 0.05, "y": 0.05 }, "kind": "title", "text": "Promising Value Proposition to MG Patients", "attrs": null, "subkind": "headline", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "6ca488da-845a-44d4-9218-2d6a297061d6", "frameworkName": null, "frameworkSlug": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [ { "to": 6, "from": 4, "beatId": "9fe8841f-daa1-4a47-a2f9-a2e61182196b", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "What Could Be", "beatSlug": "sparkline-what-could-be-2", "evidence": "The before-after slide and KPI overview present the potential benefits of argenx SE's pipeline", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "loops": [ { "to": 6, "from": 4, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "ecfed2d1-84f5-4f61-b7a6-1bfbe0816e8d", "evidence": "The before-after slide and KPI overview present the potential benefits of argenx SE's pipeline", "position": 0, "objective": "Highlight the benefits of argenx SE's pipeline", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }